IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+8.3%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$130M
AUM Growth
–
Cap. Flow
+$130M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
49.66%
Holding
62
New
52
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Amgen
AMGN
|
$11.4M |
| 2 |
Merck
MRK
|
$8.76M |
| 3 |
Biogen
BIIB
|
$8.39M |
| 4 |
Zimmer Biomet
ZBH
|
$7.46M |
| 5 |
Gilead Sciences
GILD
|
$6.38M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 83.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSRO
51
DELISTED
TESARO, Inc.
TSRO
| $424K | 0.24% |
+15,000
| New | +$424K |
|
|
AXDX
52
DELISTED
Accelerate Diagnostics
AXDX
| $305K | 0.17% |
+25,000
| New | +$305K |
|
|
FRX
53
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
0
| – | – |
|
|
AMRN
54
Amarin Corp
AMRN
$314M
| – | – |
0
| – | – |
|
55
Quest Diagnostics
DGX
$20.3B
| – | – |
0
| – | – |
|
56
iShares Russell 2000 ETF
IWM
$66.2B
| – | – |
0
| – | – |
|
57
Sangamo Therapeutics
SGMO
$163M
| – | – |
0
| – | – |
|
58
SPDR S&P 500 ETF Trust
SPY
$649B
| – | – |
0
| – | – |
|
59
Supernus Pharmaceuticals
SUPN
$2.55B
| – | – |
0
| – | – |
|
60
United Therapeutics
UTHR
$18.9B
| – | – |
0
| – | – |
|
|
INFI
61
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
0
| – | – |
|
|
MDCO
62
DELISTED
Medicines Co
MDCO
| – | – |
0
| – | – |
|